A well-characterised peak identification list of MALDI MS profile peaks for human blood serum

Proteomics

Volumn 10, Issue 18, 2010, Pages 3388-3392

  Tiss, Ali ^a   Smith, Celia ^a   Menon, Usha ^b   Jacobs, Ian ^b   Timms, John F ^b   Cramer, Rainer ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

MALDI; MS MS peak identification; Serum profiling; Technology

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; ELECTRON SPIN RESONANCE; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SERUM;

HUMANS; MOLECULAR WEIGHT; SERUM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77956548344     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000100     Document Type: Article

References (23)

1. Callesen, A. K., Madsen, J. S., Vach, W., Kruse, T. A. et al., Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool? Proteomics 2009, 9, 1428-1441.
2. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
3. Villanueva, J., Philip, J., Chaparro, C. A., Li, Y. et al., Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res. 2005, 4, 1060-1072.
4. West-Norager, M., Kelstrup, C. D., Schou, C., Hogdall, E. V. et al., Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 847, 30-37. (Pubitemid 46216199)
5. Taguchi, F., Solomon, B., Gregorc, V., Roder, H. et al., Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study. J. Natl. Cancer Inst. 2007, 99, 838-846.
6. Fiedler, G. M., Leichtle, A. B., Kase, J., Baumann, S. et al., Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Clin. Cancer Res. 2009, 15, 3812-3819.
7. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W. et al., Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005, 5, 3226-3245.
8. Schenk, S., Schoenhals, G. J., de Souza, G.,Mann, M., A high confidence, manually validated human blood plasma protein reference set. BMC Med. Genomics 2008, 1, 41.
9. Harper, R. G., Workman, S. R., Schuetzner, S., Timperman, A. T., Sutton, J. N., Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry. Electrophoresis 2004, 25, 1299-1306.
10. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J. et al., Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2003, 2, 1096-1103.
11. Villanueva, J., Shaffer, D. R., Philip, J., Chaparro, C. A. et al., Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest. 2006, 116, 271-284.
12. Koomen, J. M., Li, D., Xiao, L. C., Liu, T. C. et al., Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J. Proteome Res. 2005, 4, 972-981. (Pubitemid 40863287)
13. Timms, J. F., Cramer, R., Camuzeaux, S., Tiss, A. et al., Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer. Clin. Chem. 2010, 56, 262-271.
14. Peng, J., Stanley, A. J., Cairns, D., Selby, P. J., Banks, R. E., Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles - initial evaluation using low molecular weight serum peaks. Proteomics 2009, 9, 492-498.
15. Bakun, M., Karczmarski, J., Poznanski, J., Rubel, T. et al., An integrated LC-ESI-MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study. Proteomics Clin. Appl. 2009, 3, 932-946.
16. Antwi, K., Hostetter, G., Demeure, M. J., Katchman, B. A. et al., Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors. J. Proteome Res. 2009, 8, 4722-4731.
17. Hu, L., Zhou, H., Li, Y., Sun, S. et al., Profiling of endogenous serum phosphorylated peptides by titanium (IV) immobilized mesoporous silica particles enrichment and MALDI-TOFMS detection. Anal. Chem. 2009, 81, 94-104.
18. Liang, T., Wang, N., Li, W., Li, A. et al., Identification of complement C3f-desArg and its derivative for acute leukemia diagnosis and minimal residual disease assessment. Proteomics 2010, 10, 90-98.
19. Marshall, J., Kupchak, P., Zhu, W., Yantha, J. et al., Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res. 2003, 2, 361-372.
20. Zhang, Z., Bast, R. C., Jr., Yu, Y., Li, J. et al., Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004, 64, 5882-5890.
21. Orvisky, E., Drake, S. K., Martin, B. M., Abdel-Hamid, M. et al., Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics 2006, 6, 2895-2902.
22. Pang, R. T., Poon, T. C., Chan, K. C., Lee, N. L. et al., Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome. Clin. Chem. 2006, 52, 421-429.
23. Koomen, J. M., Shih, L. N., Coombes, K. R., Li, D. et al., Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin. Cancer Res. 2005, 11, 1110-1118. (Pubitemid 40175760)